Nasic (Xylometazoline Hydrochloride, Dexpanthenol)

Xylometazoline Hydrochloride acts as a selective alpha‑adrenergic receptor agonist. When applied to the nasal mucosa, it triggers vasoconstriction of the small blood vessels, which reduces swelling and opens the nasal passages, providing rapid decongestion.

The appropriate dose of Nasic is determined by a qualified healthcare professional based on the patient’s age, condition severity, and response to therapy. Users should follow the prescriber’s instructions and the product label for the number of sprays per nostril and treatment duration.

Safety data for Nasic in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should consult their physician before using the product to weigh potential benefits against any unknown risks.

To place an order, submit an enquiry on the Nasic product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Nasic combines an alpha‑adrenergic decongestant (xylometazoline) with a mucosal protectant (dexpanthenol), offering both rapid relief and support for nasal tissue healing. Compared with single‑agent decongestants, it may reduce irritation and promote faster mucosal recovery, though clinical choice depends on individual patient needs.

Store Nasic at room temperature, preferably below 25 °C. Keep the bottle tightly closed, protect it from moisture and direct sunlight, and retain it in the original packaging until use to maintain product stability.

Nasic is administered intranasally as a spray. The usual instruction is to tilt the head slightly forward, insert the nozzle into one nostril, and spray the prescribed number of sprays while breathing in gently. Repeat in the other nostril if directed by the prescriber.

Serious adverse events, though rare, can include persistent nasal bleeding, severe hypertension, allergic reactions such as rash or angioedema, and, with prolonged misuse, nasal septum perforation. Users should discontinue the product and seek medical attention if any of these occur.

Nasic should be avoided in individuals with known hypersensitivity to xylometazoline, dexpanthenol, or any excipients in the formulation. It is also contraindicated in patients with severe hypertension, certain cardiovascular disorders, or those who have experienced rebound congestion from overuse of topical decongestants.